NCT07895381

A Study to Describe Patient REal-world FitusiRan ExpeRience

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-10-07Est. Completion: 2029-03-02

Enrollment target: 100 participants

Locations

Contact

Trial Transparency email recommended (Toll free for US & Canada)Contact-US@sanofi.com 800-633-1610

Hemophilia

This is a parallel, Phase 3, two-arm, open-label study to evaluate the efficacy and safety of treatment with fitusiran p…

Los Angeles, United StatesEst. completion Aug 4, 2029

Hemophilia A and B

Hemophilia is an inherited bleeding disorder characterized by recurrent musculoskeletal bleeding, particularly into join…

Istanbul, Turkey (Türkiye)Completed Sep 15, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.